These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8718447)

  • 1. U.K. prospective diabetes study.
    Tubner RC; Cull CA; Holman RR
    Diabetes Care; 1996 Feb; 19(2):182-3. PubMed ID: 8718447
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin and oral hypoglycemic agents.
    Price MJ
    Nurs Clin North Am; 1983 Dec; 18(4):687-706. PubMed ID: 6359069
    [No Abstract]   [Full Text] [Related]  

  • 3. Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene.
    Tonini G; Bizzarri C; Bonfanti R; Vanelli M; Cerutti F; Faleschini E; Meschi F; Prisco F; Ciacco E; Cappa M; Torelli C; Cauvin V; Tumini S; Iafusco D; Barbetti F;
    Diabetologia; 2006 Sep; 49(9):2210-3. PubMed ID: 16816952
    [No Abstract]   [Full Text] [Related]  

  • 4. [Regadrin treatment of diabetes mellitus].
    Hohlfeld R; Neugebauer A; Haaser B; Marek H; Reuter W
    Z Gesamte Inn Med; 1973 May; 28(10):Suppl 10:154-6. PubMed ID: 4734038
    [No Abstract]   [Full Text] [Related]  

  • 5. Glucose tolerance, plasma insulin and lipids in diabetic subjects before and after treatment with a new sulfonylurea compounds, Ro 6-4563.
    Berchtold P; Björntorp P; Gustafson A; Jonsson A; Fagerberg SE
    Eur J Clin Pharmacol; 1971 Dec; 4(1):22-8. PubMed ID: 5151389
    [No Abstract]   [Full Text] [Related]  

  • 6. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
    Tattersall RB
    Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219
    [No Abstract]   [Full Text] [Related]  

  • 7. [Differential therapy using oral antidiabetics].
    Mehnert H
    Internist (Berl); 1971 Nov; 12(11):468-75. PubMed ID: 4943878
    [No Abstract]   [Full Text] [Related]  

  • 8. Update on diabetes mellitus.
    Moss JM
    Med Times; 1981 Aug; 109(8):70-3. PubMed ID: 7024704
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical evaluation of glibornuride (glutril): a new oral antidiabetic drug.
    van der Merwe M; van Rooyen R
    S Afr Med J; 1973 Sep; 47(36):1638-42. PubMed ID: 4746966
    [No Abstract]   [Full Text] [Related]  

  • 10. Advances in treating diabetes with aerosolized insulin.
    Laube BL
    Diabetes Technol Ther; 2002; 4(4):515-8. PubMed ID: 12396746
    [No Abstract]   [Full Text] [Related]  

  • 11. Managing the diabetic patient with acute myocardial infarction.
    Fisken RA
    Diabet Med; 1998 Nov; 15(11):980. PubMed ID: 9827854
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical and metabolic observations with a new synthetic oral antidiabetic agent, glipizide.
    D'Onofrio F; Pempinello R; Romis L
    Arzneimittelforschung; 1972 Nov; 22(11):1879-81. PubMed ID: 4679059
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diamicron].
    Journ Annu Diabetol Hotel Dieu; 1972; 13(0):343-9. PubMed ID: 4679568
    [No Abstract]   [Full Text] [Related]  

  • 14. [Oral diabetes therapy. Possibilities and limits].
    Bachmann W
    Internist (Berl); 1981 Apr; 22(4):204-10. PubMed ID: 7014509
    [No Abstract]   [Full Text] [Related]  

  • 15. [Medium term effect (3 months) of hypoglycemic sulfamide treatment (gliclazide) on insulin secretion of the non-insulin dependent diabetic].
    Brogard JM; Pinget M; Leconte A; Dorner M
    Rev Med Interne; 1982 Dec; 3(4):379-87. PubMed ID: 6761818
    [No Abstract]   [Full Text] [Related]  

  • 16. [The therapeutic value of combined treatment with biguanides and sulfonylurea preparations in the presence of resistance to sulfanilamide drugs in diabetes mellitus patients].
    Penchev I; Andreev D; Popov A; Pampulov L
    Probl Endokrinol (Mosk); 1970; 16(6):3-7. PubMed ID: 5521087
    [No Abstract]   [Full Text] [Related]  

  • 17. Modifications of glycemia and insulinemia in diabetics treated with glipizide (K 4024), a new sulfonylurea.
    Fedele D; Tiengo A; Riva F; Muggeo M; Emanueli A; Crepaldi G
    Arzneimittelforschung; 1972 Nov; 22(11):1885-8. PubMed ID: 4679060
    [No Abstract]   [Full Text] [Related]  

  • 18. [Content of immunoreactive insulin in the plasma and insulin sensitivity in patients with diabetes mellitus during the process of sulfanilamide compensation of metabolic disorders].
    Bogatyreva ShI; Dzeranova NIa; Shlimovich PB
    Probl Endokrinol (Mosk); 1972; 18(3):22-5. PubMed ID: 5029279
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical comparison between glipentide (Staticum) and glibenclamide in diabetics.
    Moncada Lorenzo E; Garcia RV; Barberia Layana JJ; Morant Ciscard JA; Calleja Canelas A
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):50-7. PubMed ID: 401712
    [No Abstract]   [Full Text] [Related]  

  • 20. A controlled clinical trial of a new oral hypoglycemic agent, glipizide (K 4024).
    Lentini S; Bossini A; Pirola LC
    Arzneimittelforschung; 1972 Jul; 22(7):1169-73. PubMed ID: 4678124
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.